Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Family Studies of Whim Syndrome

David C. Dale, MD, Emily Dick, BA, Merideth L. Kelley, MSc, Vahagn Makaryan, MD, Jim Connelly, MD, Audrey Anna Bolyard, RN, BS

Blood (2019) 134 (Supplement_1): 215.

https://doi.org/10.1182/blood-2019-126234

Published: 2019

Journal Articles

Determination of Phase 3 Dose for X4P-001 in Patients with WHIM Syndrome

David C Dale, MD, Frank Caleb Firkin, MD, Audrey Anna Bolyard, RN, BS, Merideth L. Kelley, MSc, Emily Dick, BA, Sonja Hartmann, PhD, Karen Brown, PhD, Tarek M Ebrahim, MD, Kenneth J Gorelick, MD, Sudha Parasuraman, MD

Blood (2018) 132 (Supplement 1): 1102.

https://doi.org/10.1182/blood-2018-99-119840

Published: 2018

Journal Articles

How I treat warts, hypogammaglobulinemia, infections, and myelokathexis syndrome

Raffaele Badolato, Jean Donadieu, the WHIM Research Group

Blood (2017) 130 (23): 2491–2498.

https://doi.org/10.1182/blood-2017-02-708552

Published: 2017

Journal Articles

X4P-001: A Novel Molecularly-Targeted Oral Therapy for Whim Syndrome

David Dale, MD, Audrey Anna Bolyard, RN, BS, Emily Dick, BA, Merideth L. Kelley, MS, Vahagn Makaryan, MD, Ramsey Johnson, MSM, Lu Gan, MD PhD, Sudha Parasuraman, MD

Blood (2017) 130 (Supplement 1): 995.

https://doi.org/10.1182/blood.V130.Suppl_1.995.995

Published: 2017

Journal Articles

CXCR4 Gene Dosage Is Critical for HSC Engraftment

David H. McDermott, MD, Paejonette Jacobs, PhD, Qian Liu, MD, Jiliang Gao, PhD, Philip M. Murphy, MD

Blood (2015) 126 (23): 3066.

https://doi.org/10.1182/blood.V126.23.3066.3066

Published: 2015

Journal Articles

Allogeneic Stem Cell Transplantation in a Pediatric Patient with Whim Syndrome

Saleh Bhar, MD, Khaled Yassine, MD, Caridad Martinez, MD, Ghadir S. Sasa, MD, Swati Naik, MD, Donald Mahoney, Jr., MD, Carl Allen, MD PhD, Nabil Ahmed, MD, Meenakshi G. Hegde, MD, Helen E. Heslop, MD, Stephen Gottschalk, MD, Robert A. Krance, MD, Kathryn S. Leung

Blood (2015) 126 (23): 5528.

https://doi.org/10.1182/blood.V126.23.5528.5528

Published: 2015

Journal Articles

Whim Syndrome Caused By a 5 Base Pair Deletion in the C-Terminus of Chemokine Receptor CXCR4

Qian Liu, MD, Lizbeeth Lopez, Catherina Pan, Daniel Velez, John S. Corns, Donald T. Ellenburg, Harry L. Malech, MD, Philip M. Murphy, MD, David H. McDermott, MD

Blood (2015) 126 (23): 1003.

https://doi.org/10.1182/blood.V126.23.1003.1003

Published: 2015

Journal Articles

How I treat Waldenström macroglobulinemia

Steven P. Treon

Blood (2015) 126 (6): 721–732.

https://doi.org/10.1182/blood-2015-01-553974

Published: 2015

Journal Articles

Application of Novel Next Generation Sequencing Gene Panel Assay to Genetic and Clinical Diagnosis of Inherited Bone Marrow Failure Syndromes

Blood (2014) 124 (21): 257.

https://doi.org/10.1182/blood.V124.21.257.257

Published: 2014

Journal Articles

Somatic Activating Mutations In CXCR4 Are Common In Patients With Waldenstrom’s Macroglobulinemia, and Their Expression In WM Cells Promotes Resistance To Ibrutinib

Yang Cao, MD, Zachary Hunter, Xia Liu, MD, Lian Xu, Guang Yang, PhD, Christina K Tripsas, MA, Robert Manning, Christopher Patterson, Steven Peter Treon, MD, MA, PhD

Blood (2013) 122 (21): 4424.

https://doi.org/10.1182/blood.V122.21.4424.4424

Published: 2013

Journal Articles

Acquired Whim Syndrome: A Possible New Side Effect Of Dasatinib!

Satya Prakash Yadav, MBBS, Mohammed Ramzan, Yogi Raj Chopra, Nivedita Dhingra, Anupam Sachdeva, MD

Blood (2013) 122 (21): 4933.

https://doi.org/10.1182/blood.V122.21.4933.4933

Published: 2013

Journal Articles

Mechanisms of Neutrophil Release from the Bone Marrow

Daniel Link, MD

Blood (2013) 122 (21): SCI-43.

https://doi.org/10.1182/blood.V122.21.SCI-43.SCI-43

Published: 2013

Journal Articles

On a WHIM

Charles M. van Slambrouck, Sandeep Gurbuxani

Blood (2013) 121 (6): 875.

https://doi.org/10.1182/blood-2012-03-420091

Published: 2013

Journal Articles

Whole Genome Sequencing Identifies Recurring Somatic Mutations in the C-Terminal Domain of CXCR4, Including a Gain of Function Mutation in Waldenstrom's Macroglobinemia.

Yang Cao, MD, Lian Xu, Xia Liu, MD, Yangsheng Zhou, MD, Guang Yang, MD, Christopher J Patterson, Steven Peter Treon, MD, MA, PhD, Zachary Hunter

Blood (2012) 120 (21): 2715.

https://doi.org/10.1182/blood.V120.21.2715.2715

Published: 2012

Journal Articles

The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome

David C. Dale, Audrey Anna Bolyard, Merideth L. Kelley, Ernest C. Westrup, Vahagn Makaryan, Andrew Aprikyan, Brent Wood, Frank J. Hsu

Blood (2011) 118 (18): 4963–4966.

https://doi.org/10.1182/blood-2011-06-360586

Published: 2011

Journal Articles

Released on a WHIM

George A. Diaz

Blood (2011) 118 (18): 4764–4765.

https://doi.org/10.1182/blood-2011-08-375162

Published: 2011

Journal Articles

Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients

Laura Tassone, Daniele Moratto, William Vermi, Maria De Francesco, Lucia D. Notarangelo, Fulvio Porta, Vassilios Lougaris, Fabio Facchetti, Alessandro Plebani, Raffaele Badolato

Blood (2010) 116 (23): 4870–4873.

https://doi.org/10.1182/blood-2010-03-272096

Published: 2010

Includes: Supplemental data

Journal Articles

Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis

David H. McDermott, Suk See De Ravin, Hyun Sik Jun, Qian Liu, Debra A. Long Priel, Pierre Noel, Clifford M. Takemoto, Teresa Ojode, Scott M. Paul, Kimberly P. Dunsmore, Dianne Hilligoss, Martha Marquesen, Jean Ulrick, Douglas B. Kuhns, Janice Y. Chou, Harry L. Malech, Philip M. Murphy

Blood (2010) 116 (15): 2793–2802.

https://doi.org/10.1182/blood-2010-01-265942

Published: 2010

Journal Articles

Mutant CXCR4-Induced Aberrant Retention and Apoptosis of Hematopoietic Cells in Myelokathexis and Normalization of Cell Survival and Mobilization with Specific Inhibitors.

Vahagn Makaryan, MD, Oscar Penate, MD, David C. Dale, MD, Andrew A Aprikyan, PhD

Blood (2009) 114 (22): 237.

https://doi.org/10.1182/blood.V114.22.237.237

Published: 2009

Journal Articles

CXCR2 Signals Act in Concert with CXCR4 to Regulate Neutrophil Release From the Bone Marrow.

Kyle J Eash, Adam M. Greenbaum, Priya Gopalan, MD, PhD, George A. Diaz, MD, PhD, Daniel C. Link, MD

Blood (2009) 114 (22): 235.

https://doi.org/10.1182/blood.V114.22.235.235

Published: 2009

NARROW

Family Studies of Whim Syndrome

Determination of Phase 3 Dose for X4P-001 in Patients with WHIM Syndrome

How I treat warts, hypogammaglobulinemia, infections, and myelokathexis syndrome

X4P-001: A Novel Molecularly-Targeted Oral Therapy for Whim Syndrome

CXCR4 Gene Dosage Is Critical for HSC Engraftment

Allogeneic Stem Cell Transplantation in a Pediatric Patient with Whim Syndrome

Whim Syndrome Caused By a 5 Base Pair Deletion in the C-Terminus of Chemokine Receptor CXCR4

How I treat Waldenström macroglobulinemia

Application of Novel Next Generation Sequencing Gene Panel Assay to Genetic and Clinical Diagnosis of Inherited Bone Marrow Failure Syndromes

Somatic Activating Mutations In CXCR4 Are Common In Patients With Waldenstrom’s Macroglobulinemia, and Their Expression In WM Cells Promotes Resistance To Ibrutinib

Acquired Whim Syndrome: A Possible New Side Effect Of Dasatinib!

Mechanisms of Neutrophil Release from the Bone Marrow

On a WHIM

Whole Genome Sequencing Identifies Recurring Somatic Mutations in the C-Terminal Domain of CXCR4, Including a Gain of Function Mutation in Waldenstrom's Macroglobinemia.

The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome

Released on a WHIM

Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients

Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis

Mutant CXCR4-Induced Aberrant Retention and Apoptosis of Hematopoietic Cells in Myelokathexis and Normalization of Cell Survival and Mobilization with Specific Inhibitors.

CXCR2 Signals Act in Concert with CXCR4 to Regulate Neutrophil Release From the Bone Marrow.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only